BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27835877)

  • 1. O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer.
    Santos SN; Junqueira MS; Francisco G; Vilanova M; Magalhães A; Dias Baruffi M; Chammas R; Harris AL; Reis CA; Bernardes ES
    Oncotarget; 2016 Dec; 7(50):83570-83587. PubMed ID: 27835877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
    Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
    J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens.
    Ikehara Y; Kojima N; Kurosawa N; Kudo T; Kono M; Nishihara S; Issiki S; Morozumi K; Itzkowitz S; Tsuda T; Nishimura SI; Tsuji S; Narimatsu H
    Glycobiology; 1999 Nov; 9(11):1213-24. PubMed ID: 10536037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.
    Tamura F; Sato Y; Hirakawa M; Yoshida M; Ono M; Osuga T; Okagawa Y; Uemura N; Arihara Y; Murase K; Kawano Y; Iyama S; Takada K; Hayashi T; Sato T; Miyanishi K; Kobune M; Takimoto R; Kato J
    Gastric Cancer; 2016 Jan; 19(1):85-97. PubMed ID: 25532910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.
    Julien S; Krzewinski-Recchi MA; Harduin-Lepers A; Gouyer V; Huet G; Le Bourhis X; Delannoy P
    Glycoconj J; 2001; 18(11-12):883-93. PubMed ID: 12820722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
    Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
    Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
    Julien S; Adriaenssens E; Ottenberg K; Furlan A; Courtand G; Vercoutter-Edouart AS; Hanisch FG; Delannoy P; Le Bourhis X
    Glycobiology; 2006 Jan; 16(1):54-64. PubMed ID: 16135558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
    Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
    HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization.
    Fujita R; Hamano H; Kameda Y; Arai R; Shimizu T; Ota M; Sato D; Kobayashi H; Iwasaki N; Takahata M
    Clin Exp Metastasis; 2019 Dec; 36(6):539-549. PubMed ID: 31595388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of ST6GalNAc I suppresses the proliferation, migration and invasion of hepatocarcinoma cells through PI3K/AKT/NF-κB pathway.
    Yu X; Wu Q; Wang L; Zhao Y; Zhang Q; Meng Q; Pawan ; Wang S
    Tumour Biol; 2016 Sep; 37(9):12213-12221. PubMed ID: 27235117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the glycophenotype of squamous epithelia using plant and mammalian lectins. Differentiation-dependent expression of alpha2,6- and alpha2,3-linked N-acetylneuraminic acid in squamous epithelia and carcinomas, and its differential effect on binding of the endogenous lectins galectins-1 and -3.
    Holíková Z; Hrdlicková-Cela E; Plzák J; Smetana K; Betka J; Dvoránková B; Esner M; Wasano K; André S; Kaltner H; Motlík J; Hercogová J; Kodet R; Gabius HJ
    APMIS; 2002 Dec; 110(12):845-56. PubMed ID: 12645662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of sialyl-Tn epitopes on beta1 integrin alters epithelial cell phenotype, proliferation and haptotaxis.
    Clément M; Rocher J; Loirand G; Le Pendu J
    J Cell Sci; 2004 Oct; 117(Pt 21):5059-69. PubMed ID: 15383613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation analysis between tumor-associated antigen sialyl-Tn expression and ST6GalNAc I activity in human colon adenocarcinoma.
    Vázquez-Martín C; Cuevas E; Gil-Martín E; Fernández-Briera A
    Oncology; 2004; 67(2):159-65. PubMed ID: 15539921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration.
    Julien S; Lagadec C; Krzewinski-Recchi MA; Courtand G; Le Bourhis X; Delannoy P
    Breast Cancer Res Treat; 2005 Mar; 90(1):77-84. PubMed ID: 15770530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation.
    Lakshmanan I; Chaudhary S; Vengoji R; Seshacharyulu P; Rachagani S; Carmicheal J; Jahan R; Atri P; Chirravuri-Venkata R; Gupta R; Marimuthu S; Perumal N; Rauth S; Kaur S; Mallya K; Smith LM; Lele SM; Ponnusamy MP; Nasser MW; Salgia R; Batra SK; Ganti AK
    Mol Oncol; 2021 Jul; 15(7):1866-1881. PubMed ID: 33792183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
    Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
    Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
    Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
    Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of galectin-3 in cancer drug resistance.
    Fukumori T; Kanayama HO; Raz A
    Drug Resist Updat; 2007 Jun; 10(3):101-8. PubMed ID: 17544840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues.
    Marcos NT; Bennett EP; Gomes J; Magalhaes A; Gomes C; David L; Dar I; Jeanneau C; DeFrees S; Krustrup D; Vogel LK; Kure EH; Burchell J; Taylor-Papadimitriou J; Clausen H; Mandel U; Reis CA
    Front Biosci (Elite Ed); 2011 Jun; 3(4):1443-55. PubMed ID: 21622148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.